Major trial aims to halt prostate cancer spread with targeted radiation blitz
NCT ID NCT07426094
Summary
This trial is for men whose prostate cancer has spread to nearby pelvic lymph nodes but not further. It aims to find the best way to use high-dose, targeted radiation to control the disease and prevent it from spreading to other parts of the body. The study will compare focusing extra radiation on the prostate itself versus boosting both the prostate and the affected lymph nodes. All participants will receive a short, intensive course of radiation to the whole pelvis along with standard hormone therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affidea Nu-Med, Center of Oncological Diagnostics and Therapy
RECRUITINGZamość, Lublin Voivodeship, 22-400, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.